IP Verse

Biontech Cell & Gene Therapies competitive analysis

Loading summary...

Latest oppositions filed by Biontech Cell & Gene Therapies

Explore patent oppositions filed by Biontech Cell & Gene Therapies against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3170842
Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use ThereofCAFA THERAPEUTICSJun 4, 2020

Latest publications and patents of Biontech Cell & Gene Therapies New

Explore the latest publications and patents granted to Biontech Cell & Gene Therapies, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Biontech Cell & Gene Therapies

Discover the latest PTAB cases involving Biontech Cell & Gene Therapies, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Biontech Cell & Gene Therapies with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIONTECH CELL & GENE THERAPIES1 - - -
CAFA THERAPEUTICS - 3 - -
CARSGEN THERAPEUTICS - 3 - -
CRAGE MEDICAL - 3 - -